Literature DB >> 31511736

Treatment options for paediatric brainstem gliomas.

Daniyal Aziz Khan1, Altaf Ali Laghari1, Muhammad Ehsan Bari1, Muhammad Shahzad Shamim1.   

Abstract

Paediatric brainstem gliomas (BSGs) can be classified broadly into two distinct categories: focal brainstem gliomas (FBSGs) and diffuse intrinsic pontine gliomas (DIPG). The former account for 20% of paediatric BSGs and are mostly indolent lesions with good prognosis. DIPGs constitute the remaining 80%, and are highly aggressive, malignant tumours having a dismal prognosis; being the foremost cause of death in children with brain tumours. Their poor response to treatment regimens is further complicated by their localization in eloquent brainstem areas, thereby making it difficult to establish a standardized framework of therapeutic intervention. In this review, the authors catalogue and appraise current treatment modalities utilized in the management of paediatric BSGs including steroid use, chemotherapy, radiotherapy, and surgery.

Entities:  

Keywords:  Diffuse intrinsic pontine glioma (DIPG), Paediatric brains temgliom as, Radio therapy.

Mesh:

Substances:

Year:  2019        PMID: 31511736

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Diagnostic accuracy of magnetic resonance imaging in detection of intra-axial gliomas.

Authors:  Sohbia Munir; Sohail Ahmed Khan; Hina Hanif; Maria Khan
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

2.  lncRNA MEG3 Inhibits the Proliferation and Growth of Glioma Cells by Downregulating Bcl-xL in the PI3K/Akt/NF-κB Signal Pathway.

Authors:  Haibo Jia; Xiaoxiao Yan
Journal:  Biomed Res Int       Date:  2022-07-11       Impact factor: 3.246

3.  Prediction of Cancer-Specific Survival of Brainstem Glioma in Children Based on Risk Stratification Model.

Authors:  Kai Sun; Mingwei Xu; Xiaowei Fei; Hao Wang; Lunshan Xu; Ruxiang Xu; Minhui Xu
Journal:  Comput Math Methods Med       Date:  2022-07-20       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.